2-(Perfluorobutyl)ethyl acrylate Cas:52591-27-2

We are 2-(Perfluorobutyl)ethyl acrylate CAS:52591-27-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

2-(Perfluorobutyl)ethyl acrylate

1H,1H,2H,2H-Nonafluorohexyl Acrylate
Acrylic Acid 1H,1H,2H,2H-Nonafluorohexyl Ester
3,3,4,4,5,5,6,6,6-Nonafluorohexyl Acrylate
1H,1H,2H,2H-Perfluorohexyl acrylate
2-Propenoic acid 3,3,4,4,5,5,6,6,6-nonafluorohexyl ester
Acrylic acid 3,3,4,4,5,5,6,6,6-nonafluorohexyl ester
Propenoic acid 3,3,4,4,5,5,6,6,6-nonafluorohexyl ester
Molecular Formula: C9H7F9O2
Molecular weight:318.13600
Density: 1.414
Boiling point: 164ºC
Flash point: 52ºC
Refractive index: 1.31

Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.

Market News:The manufacturing chief pointed to some of the cutting-edge technology Takeda will roll out at the upgraded facility, such as automation and robotics, plus virtual reality equipment and training. 5-Acetoxy-6-phenyl-pyridine-2-carboxylic acid methyl ester manufacturer.“This is the beginning of the next chapter of growth for BetterUp, and we are not slowing down” 2-(3-Thiacoumarinyl)benzimidazol supplier.Novartis and GSK carried out a swap of its vaccine and cancer drugs back in 2015. GSK paid $5.25 billion to Novartis for its vaccine business, and Novartis sent $16 billion for GSK’s oncology programs. Tafinlar and Mekinist had already been granted FDA approval at the time of that deal, and as a part of that deal, Novartis agreed to divest its own BRAF and MEK inhibitors to avoid creating a monopoly. 2-hydroperoxy-3-(44,54,63-octaoxidan-4,5-dienyl)-13,24,34,43,53,63-hexaoxine producer.

Related Products
Product Name
Cytarabine View Details
Sodium Carbonate 99.999% Cas:497-19-8 View Details
Cocoyl chloride Cas:68187-89-3 View Details
2-nitro-p-toluidine manufacturer 1,8-DIBROMONAPHTALENE Cas:17135-74-9 manufacturer boron trifluoride etherate Cas:109-63-7 manufacturer polyglyceryl-3 ricinoleate Cas:29894-35-7 manufacturer 1-Hydroxyethylethoxypiperazine Cas:13349-82-1 manufacturer